COVID-19 Treatment - Wake Research

COVID-19 Treatment

Diagnosed with COVID-19?

Experiencing COVID-19 symptoms in the last 24 hours? You or a family member may be eligible for a clinical research study.

To qualify, you must:

  • Pediatric participants 12-17 years old or adult participants (of any age)
  • The index participant must:
    1. have at least 1 COVID-19 symptom within 24 hours.
    2. have positive COVID-19 test from any respiratory tract specimen from a sample collected

Qualified participants may receive:

  • Study-related medication at no cost
  • Study-related medical exams at no cost
  • Compensation for time and travel

*Other conditions may apply

Why Participate?

Contribute to the advancement of medical knowledge and treatments, while receiving expert medical care under close supervision.


The M3 Wake Research Network has powered innovation with over 9,100 Successful Clinical Trials in patients from 6 months to 85 years.


Patient safety is paramount with strict protocols and ethical guidelines, minimizing risks and ensuring thorough monitoring throughout the trial.

Global Medical Research

Study Hotline

Main Office 

Our Hours
Mon-Fri: 9AM to 5PM

2701 S. Hampton Rd. Suite 250
Dallas TX, 75224